 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | JD010 / Beijing JD Biotech
New P1 trial: CAR-NK Targeted CD19 for r/r B-cell Malignancies (clinicaltrials.gov) - Dec 9, 2022
P1, N=12, Recruiting, Sponsor: Affiliated Hospital to Academy of Military Medical Sciences